(+)-Naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats

Ähnliche Einträge

• Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)
  von: Hutchinson, Mark R., et al.
  Veröffentlicht: (2008)
• Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4
  von: Wang, X, et al.
  Veröffentlicht: (2016)
• The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia
  von: Watkins, Linda R., et al.
  Veröffentlicht: (2009)
• Possible involvement of Toll-Like Receptor 4/MD-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences
  von: Hutchinson, Mark R., et al.
  Veröffentlicht: (2010)
• Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β
  von: Lewis, Susannah S., et al.
  Veröffentlicht: (2010)